Berry Street’s new GLP-1 nutrition program supports patients who are starting GLP-1s, currently taking them or transitioning off of them. Patients receive care from registered dietitians and certified nutrition specialists. The post Berry Street Introduces GLP-1 Nutrition Program appeared first on MedCity News.
Trellis Health emerged from stealth and announced $1.8 million in pre-seed funding. The platform helps women easily access and understand their medical records so they can make better health decisions during pregnancy and throughout their lives. The post New Pregnancy App Launches to Support Mothers Through Birth and Beyond appeared first on MedCity News.
In this episode, we’re joined by Kathryn Schubert, president and CEO of the Society for Women’s Health Research. Schubert discusses the trends in women’s health that defined 2024 and what we can expect in the coming year. The post MedCity FemFwd: What the Future Holds for Women’s Health in 2025 appeared first on MedCity News.
As firefighters battled the catastrophic blazes in Los Angeles County in January, California’s U.S. senators, Adam Schiff and Alex Padilla, signed onto legislation with a simple aim: Provide federal assistance to first responders diagnosed with service-related cancer. The Honoring Our Fallen Heroes Act is considered crucial by its supporters, with climate change fueling an increase…
CDMO Avid Bioservices is being acquired by the private equity firms GHO Capital Partners and Ampersand Capital Partners. Avid specializes in manufacturing biologic products for companies at all stages of development. The post Private Equity Is Picking Up Biologics CDMO Avid Bioservices in $1.1B Acquisition appeared first on MedCity News.
We should ask a more nuanced question than “does AI work in drug discovery.” Rather, we should ask which approaches are about to be proven, and which are about to be exposed, because the field is several bets, and they are not equally sound. The post The AI Drug Discovery Race Is Heating Up, Not…
SpringWorks Therapeutics’ Gomekli is now FDA approved for treating tumors caused by the rare genetic disorder neurofibromatosis type 1. The approval comes as SpringWorks has emerged as a potential acquisition target. The post FDA Approval of Drug for Rare Tumors Enables SpringWorks to Challenge AstraZeneca appeared first on MedCity News.
On this blog we most often talk about health care issues related to chronic and acute conditions, health behaviors and public health. However, there is another dimension that is vital to health: avoiding natural disasters. Unfortunately, natural disasters appear to having an increasing impact in the US across the past decades. Between 1980-2024, 16,941 people…
Amy Frank said it took 17 hours on the phone over nearly three weeks, bouncing between her insurer and her local hospital system, to make sure her plan would cover her husband’s post-surgery care. Many of her calls never got past the hold music. When they did, the hospital told her to call her insurer….
About six months after rolling out voice AI in its call centers, Allina Health is already seeing signs that the tool is doing a good job of improving the patient experience. The technology is reducing patients’ average call times by 5-10 seconds, and 80% of calls are now answered in 45 seconds or less. The…